Pharmacopoeias, Drug Regulation, and Empires PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Pharmacopoeias, Drug Regulation, and Empires PDF full book. Access full book title Pharmacopoeias, Drug Regulation, and Empires by Stuart Anderson. Download full books in PDF and EPUB format.
Author: Stuart Anderson Publisher: McGill-Queen's Press - MQUP ISBN: 0228021596 Category : History Languages : en Pages : 228
Book Description
The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire. Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones. Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.
Author: Stuart Anderson Publisher: McGill-Queen's Press - MQUP ISBN: 0228021596 Category : History Languages : en Pages : 228
Book Description
The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire. Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones. Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.
Author: Stuart Anderson Publisher: Bloomsbury Publishing USA ISBN: 0313380295 Category : Political Science Languages : en Pages : 243
Book Description
Immigration is a comprehensive and practical guide to the history, economics, and contributions of immigrants, written by a former key policymaker who is now a leading researcher in the field. Immigration is a comprehensive examination of U.S. immigration policies and their impact on the nation, combining a historical overview and a guide to how immigration works in practice. In this one-volume compendium on the history, politics, culture, and contributions of immigrants to the United States, the author uses his experience in key immigration policy posts to provide an insider's perspective on a broad array of immigration-related issues. Offering a detached, unbiased analysis of the economic, fiscal, and other impacts of current immigration policies, he recommends reforms and policy solutions for the thorniest immigration issues, such as illegal immigration. But the book does not ignore the fact that immigration has always enriched and strengthened our nation. Along with policy considerations, it also encompasses enlightening profiles detailing the many contributions of individual immigrants in such diverse areas as science, sports, the military, and business.
Author: Chinese Pharmacopoeia Commission Publisher: ISBN: 9780119207798 Category : Languages : en Pages :
Book Description
Chinese Pharmacopoeia 2010 is an official and authoritative compendium of drugs. It covers most traditional Chinese medicines, most western medicines and preparations, giving information on the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug. It is published in three volumes, and contains up to 4567 monographs with 1386 new admissions. In Volume I, it contains monographs of Chinese crude drugs and the prepared slices. Vegetable oil/fat and its extract, the patented Chinese traditional medicines, single ingredient of Chinese crude drug preparations etc. it has 2165 monographs with 1019 new admissions (439 articles of the prepared slice) and 634 revised; Volume II deals with monographs of chemical drugs, antibiotics, biochemical preparations, radiopharmaceuticals and excipients for pharmaceutical use, contains 2271 monographs with 330 new admissions and 1500 revised; Volume III contains biological products, has 131 monographs with 37 new admissions and 94 revised
Author: David A. Guba Jr Publisher: McGill-Queen's Press - MQUP ISBN: 0228002559 Category : History Languages : en Pages : 313
Book Description
Despite having the highest rates of cannabis use in the continent, France enforces the most repressive laws against the drug in all of Europe. Perhaps surprisingly, France was once the epicentre of a global movement to medicalize cannabis, specifically hashish, in the treatment of disease. In Taming Cannabis David Guba examines how nineteenth-century French authorities routinely blamed hashish consumption, especially among Muslim North Africans, for behaviour deemed violent and threatening to the social order. This association of hashish with violence became the primary impetus for French pharmacists and physicians to tame the drug and deploy it in the homeopathic treatment of mental illness and epidemic disease during the 1830s and 1840s. Initially heralded as a wonder drug capable of curing insanity, cholera, and the plague, hashish was deemed ineffective against these diseases and fell out of repute by the middle 1850s. The association between hashish and Muslim violence, however, remained and became codified in French colonial medicine and law by the 1860s: authorities framed hashish as a significant cause of mental illness, violence, and anti-state resistance among indigenous Algerians. As the French government looks to reform the nation's drug laws to address the rise in drug-related incarceration and the growing popular demand for cannabis legalization, Taming Cannabis provides a timely and fascinating exploration of the largely untold and living history of cannabis in colonial France.
Author: Daniel J. Robinson Publisher: McGill-Queen's Press - MQUP ISBN: 0228005973 Category : History Languages : en Pages :
Book Description
In the 1950s, the causal link between smoking and lung cancer surfaced in medical journals and mainstream media. Yet the best years for the Canadian cigarette industry were still to come, as per capita cigarette consumption rose steadily in the 1960s and 1970s. In Cigarette Nation, Daniel Robinson examines the vibrant and contentious history of smoking to discover why Canadians continued to light up despite the publicized health risks. Highlighting the prolific marketing and advertising practices that helped make smoking a staple of everyday life, Robinson explores socio-cultural aspects of cigarette use from the 1930s to the 1950s and recounts the views and actions of tobacco executives, government officials, and Canadian smokers as they responded to mounting evidence that cigarette use was harmful. The persistence of smoking owes to such factors as product development, marketing and retailing innovation, public relations, sponsored science, and government inaction. Domestic and international tobacco firms worked to furnish Canadian smokers with hope and doubt: hope in the form of reassuring marketing, as seen with light and mild cigarette brands, and doubt by means of disinformation campaigns attacking medical research and press accounts that aligned cigarettes with serious disease. Drawing on a wide range of primary sources, including thousands of industry records released during a landmark tobacco class-action trial in 2015, Cigarette Nation documents in rich detail the history of one of Canada’s foremost public health issues.
Author: Stuart Anderson
Author: Stuart Anderson
Author: Stuart Anderson
Author: 
Author: Chinese Pharmacopoeia Commission
Author: 
Author: David A. Guba Jr
Author: Society of Comparative Legislation
Author: 
Author: Lawrence Henry Gipson
Author: Daniel J. Robinson